ECR 2013 – Final Programme - myESR.org

Postgraduate Educational Programme08:33A-369 Imaging biomarkersJ.-P. Vallée; Geneva/CHLearning Objectives:1. To understand the concept of imaging biomarkers.2. To learn about the different types of biomarkers (anatomical/functional/molecular).3. To understand the different applications of imaging biomarkers(detection, prediction, response).4. To learn about the standardisation and validation of imagingbiomarkers.08:45A-370 Imaging biomarkers for myocardial functionJ. Bogaert; Leuven/BELearning Objectives:To become familiar with the quantitative imaging biomarkers of:1) cardiac mass (MRI/CT)2) ventricular volume (MRI/CT)3) ventricular function (MRI/CT)09:05A-371 Imaging biomarkers of myocardial viabilityP. Croisille; Saint-Etienne/FRLearning Objectives:To become familiar with the quantitative imaging biomarkers of:1) infarct size using delayed enhancement (MRI/CT)2) areas at risk in myocardial infarction using T2w MRI3) cardiac contractility using cine or tag MRI after low dosedobutamine challenge09:25A-372 Imaging biomarkers of myocardial ischaemiaL. Natale; Rome/ITLearning Objectives:To become familiar with the quantitative imaging biomarkers of:1) myocardial perfusion (MRI/CT),2) cardiac contraction after high dose dobutamine challenge (MRI)3) coronary atherosclerosis (CT)Panel discussion:09:45 How should we implement quantitative biomarkers in clinicalpractice?08:30–10:00 Room F2BreastRC 1202Multi-modality breast imaging08:30A-373 Chairman‘s introductionM. Lesaru; Bucharest/RO08:35A-374 A. Conventional, functional and interventional lymph nodeassessmentP.D. Britton; Cambridge/UKLearning Objectives:1. To learn about normal lymph node morphology.2. To understand criteria suggestive of morphological abnormality.3. To become familiar with factors affecting overall sensitivity of preoperativelymph node assessment.08:58A-375 B. Multi-modality assessment of the breast followingoncoplastic surgeryM. Torres-Tabanera, S. Perez-Rodrigo; Madrid/ESLearning Objectives:1. To learn about the range of oncoplastic breast procedures in currentclinical practice.2. To become familiar with imaging features resulting from oncoplasticsurgery.3. To appreciate the potential pitfalls encountered while imaging suchcases.09:21A-376 C. Image guided therapy in breast lesions: indications andtechniquesG. Manenti, G. Simonetti; Rome/ITLearning Objectives:1. To understand indications for therapeutic interventions in malignantand benign lesions.2. To learn about current image guided therapeutic techniques inmalignant and benign lesions.3. To appreciate possible future developments of therapeuticinterventions.Panel discussion:09:44 How is the evolution of multi-modality breast imagingchanging the nature of the multi-disciplinary meeting (MDM)?08:30–10:00 Room G/HGenitourinaryRC 1207 How I reportModerator: G.M. Villeirs; Gent/BE08:30A-377 A. Female pelvis MRIA.G. Rockall; London/UKLearning Objectives:1. To learn a structured reporting approach to MR imaging.2. To learn a structured reporting approach to uterine and cervicalcancer staging.3. To learn a structured reporting approach to adnexal masses.09:00A-378 B. Prostate MRIJ.J. Fütterer; Nijmegen/NLLearning Objectives:1. To learn a structured reporting approach to MR imaging.2. To learn the most essential points and details to be reported inprostate cancer patients.3. To understand the major weaknesses of a prostate MR report.09:30A-379 C. CT urographyN.C. Cowan; Birmingham/UKLearning Objectives:1. To learn how to read and report CT urography.2. To understand how to optimise CT urography for haematuria andurothelial cancer.3. To report specimen cases and self-assess your own performance.08:30–10:00 Room I/KChestRC 1204 Lung cancer staging in 201308:30A-380 Chairman‘s introduction: the latest TNM classificationJ. Biederer; Heidelberg/DE08:35A-381 A. Local tumour stagingL. Bonomo; Rome/ITLearning Objectives:1. To learn about the T staging of lung cancer.2. To become familiar with the current state of the different imagingtechnique to assess the T stage.3. To appreciate limitations and pitfalls.A-369 – A-381Sunday189